BioCentury
ARTICLE | Financial News

AuraSense closes series B round

December 23, 2011 1:35 AM UTC

Gene therapy company AuraSense Therapeutics LLC (Evanston, Ill.) raised an undisclosed amount in a series B round. Investors included Abbott Laboratories (NYSE:ABT) subsidiary Abbott Biotech Ventures;...